Table 3.
CRA performed by the participants.
| Assay type | IncubationTime | Number of participants | Number of donors (all participants) |
|---|---|---|---|
| PBMC-SP | 18–24 h | 4 | 35 |
| 48 h | 3 | 26 | |
| PBMC-AQ | 24 h | 1 | 8 |
| PBL/HUVEC | 24 h | 1 | 8 |
| WB-AQ | 24 h | 6 | 54 |
| 48 h | 1 | 8 | |
| dWB-AQ | 48 h | 1 | 12 |
| dWB-SP* | 48 h | 1 | 15 |
PBMC: Peripheral Blood Mononuclear Cells; PBL: peripheral blood leukocytes; HUVEC: human umbilical vein endothelial cells; WB: Whole Blood; dWB: diluted Whole Blood; SP: solid phase; AQ: Aqueous Phase; dWB-SP* corresponds to the bead coated method.